Ra­mona Se­queira to be­come PhRMA's first fe­male chair; McK­in­sey reach­es near­ly $574 mil­lion set­tle­ment over in­volve­ment in opi­oid cri­sis

PhRMA is get­ting its first fe­male board chair.

On Thurs­day, the trade as­so­ci­a­tion cel­e­brat­ed news that Ra­mona Se­queira, pres­i­dent of Take­da’s US busi­ness, has been named chair-elect. The for­mer board trea­sur­er is set to step up next year, leav­ing her role to No­var­tis CEO Vas Narasimhan.

“Over the past year, the pub­lic has wit­nessed first-hand, the ben­e­fits of in­no­v­a­tive sci­ence as our in­dus­try quick­ly and safe­ly worked to­geth­er to ad­dress one of the great­est health care chal­lenges of our time,” Se­queira said in a state­ment. “Yet, there con­tin­ues to be op­por­tu­ni­ty to im­prove pub­lic per­cep­tion of our in­dus­try.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER